GlobeImmune: Still Highly Undervalued - Milestone Payments Worth $26.12 Per ShareMon, Jun. 20 • Abu Bakr Hussain • 108 Comments
Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.
GlobeImmune, Inc. is a biopharmaceutical company, which focuses on developing therapeutic products for cancer and infectious diseases based on its proprietary Tarmogen platform. The company has four product candidates in five ongoing clinical trials. It's cancer product candidate, GI-4000, is... More
Country: United States
Other News & PR